These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20226014)

  • 21. Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
    Iqbal J; Thike AA; Cheok PY; Tse GM; Tan PH
    Histopathology; 2012 Oct; 61(4):652-9. PubMed ID: 22759273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altering PI3K-Akt signalling in zebrafish embryos affects PTEN phosphorylation and gastrulation.
    Finkielsztein A; Kelly GM
    Biol Cell; 2009 Aug; 101(11):661-78, 4 p following 678. PubMed ID: 19515017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
    Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
    PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
    Saal LH; Holm K; Maurer M; Memeo L; Su T; Wang X; Yu JS; Malmström PO; Mansukhani M; Enoksson J; Hibshoosh H; Borg A; Parsons R
    Cancer Res; 2005 Apr; 65(7):2554-9. PubMed ID: 15805248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences.
    Kruger DT; Beelen KJ; Opdam M; Sanders J; van der Noort V; Boven E; Linn SC
    Br J Cancer; 2018 Oct; 119(7):832-839. PubMed ID: 30287915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
    Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
    Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Akt pathway in human breast cancer: a tissue-array-based analysis.
    Bose S; Chandran S; Mirocha JM; Bose N
    Mod Pathol; 2006 Feb; 19(2):238-45. PubMed ID: 16341149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.
    Janssen EA; Søiland H; Skaland I; Gudlaugson E; Kjellevold KH; Nysted A; Søreide JA; Baak JP
    Cell Oncol; 2007; 29(1):25-35. PubMed ID: 17429139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer.
    Carvalho S; Milanezi F; Costa JL; Amendoeira I; Schmitt F
    Virchows Arch; 2010 Mar; 456(3):235-43. PubMed ID: 20130907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of PTEN expression using tissue microarrays to determine a race-specific prognostic marker in breast cancer.
    Winter JL; Stackhouse BL; Russell GB; Kute TE
    Arch Pathol Lab Med; 2007 May; 131(5):767-72. PubMed ID: 17488163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.
    McBride SM; Perez DA; Polley MY; Vandenberg SR; Smith JS; Zheng S; Lamborn KR; Wiencke JK; Chang SM; Prados MD; Berger MS; Stokoe D; Haas-Kogan DA
    J Neurooncol; 2010 Mar; 97(1):33-40. PubMed ID: 19705067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Significance of Hsp70/Hsp90 Expression in Breast Cancer: A Systematic Review and Meta-analysis.
    Dimas DT; Perlepe CD; Sergentanis TN; Misitzis I; Kontzoglou K; Patsouris E; Kouraklis G; Psaltopoulou T; Nonni A
    Anticancer Res; 2018 Mar; 38(3):1551-1562. PubMed ID: 29491085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomic profiling of the PI3K/PTEN pathway in sporadic breast cancer.
    Nassiri I; Faghihi M; Tavassoli M
    Iran Biomed J; 2009 Apr; 13(2):79-86. PubMed ID: 19471547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
    Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
    Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of PI3K-p110α in the progression of uterine cervical neoplasia and its correlation with pAkt and DJ-1.
    Choi SK; Hong YO; Lee WM; Kim EK; Joo JE; Kim DW; Lee H
    Eur J Gynaecol Oncol; 2015; 36(4):389-93. PubMed ID: 26390688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer.
    Eralp Y; Derin D; Ozluk Y; Yavuz E; Guney N; Saip P; Muslumanoglu M; Igci A; Kücücük S; Dincer M; Aydiner A; Topuz E
    Ann Oncol; 2008 Apr; 19(4):669-74. PubMed ID: 18006896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumour effects of beta-sitosterol are mediated by AMPK/PTEN/HSP90 axis in AGS human gastric adenocarcinoma cells and xenograft mouse models.
    Shin EJ; Choi HK; Sung MJ; Park JH; Chung MY; Chung S; Hwang JT
    Biochem Pharmacol; 2018 Jun; 152():60-70. PubMed ID: 29559312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting PTEN-defined breast cancers with a one-two punch.
    Maggi LB; Weber JD
    Breast Cancer Res; 2015 Apr; 17(1):51. PubMed ID: 25888162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.